Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

ClinicalTrials.gov ID: NCT03137381

Public ClinicalTrials.gov record NCT03137381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 10:05 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of CTP-543 on hair loss in adults with chronic, moderate to severe alopecia areata.

Study identification

NCT ID
NCT03137381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Concert Pharmaceuticals
Industry
Enrollment
149 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 9, 2017 (Actual)
Primary completion
Jul 8, 2019 (Actual)
Completion
Jul 8, 2019 (Actual)
Last update posted
Jul 19, 2022

2017 – 2019

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
University of California, Irvine Irvine California 92697 —
Contour Dermatology & Cosmetic Surgery Center Rancho Mirage California 92270 —
Stanford University School of Medicine Redwood City California 94064 —
Kaiser Permanente Northern California San Francisco California 94118 —
Yale School of Medicine New Haven Connecticut 06519 —
Siperstein Dermatology Group Boynton Beach Florida 33472 —
Northwestern University Chicago Illinois 60611 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Icahn School of Medicine at Mt. Sinai New York New York 10029 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27104 —
Cleveland Clinic Cleveland Ohio 44195 —
Northwest Dermatology Portland Oregon 97210 —
Suzanne Bruce & Associates, PA Houston Texas 77056 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03137381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2022 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03137381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →